Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment Oof Myelofibrosis at EHA 2022

Press/Media

Period10 Jun 2022

Media coverage

1

Media coverage

  • TitlePresents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment Oof Myelofibrosis at EHA 2022
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date10/06/22
    PersonsJohn Mascarenhas
View all 1
View less